JAK1 and diffuse large B-cell lymphoma: Here, we show that the microtubule-stabilizing agent Taxol and the JAK1/2 inhibitor ruxolitinib effectively suppress the dissemination of DLBCL by impeding STAT3-driven migratory pathways in DLBCL.